Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CARDIFF ONCOLOGY, INC. (CRDF) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CARDIFF ONCOLOGY, INC. (CRDF), most recent 12 months reported: revenue $508K, net loss $40.05M, free cash flow -$37.97M. Latest balance sheet on file: liquid cash $34.52M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): INHIBRX BIOSCIENCES, INC. · Pluri Inc. · ProKidney Corp. · ImageneBio, Inc. · aTYR PHARMA INC · VivoSim Labs, Inc. · AIM ImmunoTech Inc. · INMUNE BIO INC.

Stock screener

Watchlist